🇺🇸 Lucentis in United States

FDA authorised Lucentis on 30 June 2006

Marketing authorisations

FDA — authorised 30 June 2006

  • Application: BLA125156
  • Marketing authorisation holder: GENENTECH
  • Status: supplemented

FDA

  • Status: approved

Lucentis in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in United States

Frequently asked questions

Is Lucentis approved in United States?

Yes. FDA authorised it on 30 June 2006; FDA has authorised it.

Who is the marketing authorisation holder for Lucentis in United States?

GENENTECH holds the US marketing authorisation.